Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
13.6K
-
Shares change
-
-11.7K
-
Total reported value, excl. options
-
$105K
-
Value change
-
-$86.8K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$7.68
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q4 2023
2 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6K shares
of 56.3M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include FMR LLC (4.8M shares), PERCEPTIVE ADVISORS LLC (4M shares), Fairmount Funds Management LLC (3.55M shares), VR Adviser, LLC (3.23M shares), Vivo Capital, LLC (2.48M shares), BlackRock Inc. (2.18M shares), VANGUARD GROUP INC (2.06M shares), ARMISTICE CAPITAL, LLC (1.58M shares), Affinity Asset Advisors, LLC (1.47M shares), and SPHERA FUNDS MANAGEMENT LTD. (1.15M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.